Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Colorado Therapeutics

Colorado Therapeutics
2015 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Series A LATEST DEAL TYPE
$2.57M LATEST DEAL AMOUNT
Description

Developer of xenogenic biologic tissue matrix products. The company develops a tissue processing technology that is focused on developing xenogenic biologic tissue matrix products and therapeutic devices for a broad range of soft tissue reinforcement, regenerative and vascular applications.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Primary Office
  • 2150 West 6th Avenue
  • Unit L
  • Broomfield, CO 80020
  • United States

+1 (303) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Colorado Therapeutics’s full profile, request a free trial.

Colorado Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 17-Apr-2017 $2.57M 00.000 Completed Startup
1. Angel (individual) 18-Apr-2016 00.00 00.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Colorado Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
Joseph Horn President & Chief Executive Officer
John Lorbiecki Chief Operating Officer
Eric Schauble Vice President, Corporate Development

Colorado Therapeutics Board Members (2)

Name Representing Role Since Contact
Info
James Gleeson Colorado Therapeutics Board Member 000 0000
Thomas Raegan Colorado Therapeutics Board Member 000 0000